How to resolve contradictions in HMGB15’s role across different stress models?
Analytical framework:
Context-dependent validation: Test HMGB15 localization under varying JA concentrations, as its cytoplasmic translocation may differ during stress .
Orthogonal assays: Combine ChIP-seq with EMSA (electrophoretic mobility shift assay) to confirm direct DNA binding at promoter regions (e.g., MYC2, MYB21 ).
Cross-species comparisons: Assess functional conservation using orthologs in crop plants (e.g., rice, wheat) under similar experimental conditions.
What strategies mitigate cross-reactivity with HMGB paralogs (e.g., HMGB14/16)?
Solutions:
Paralog-specific peptides: Design blocking peptides using divergent regions of HMGB15 (e.g., C-terminal domains) during antibody incubation .
Dual antibody validation: Use two antibodies targeting distinct epitopes (e.g., N-terminal vs. C-terminal) to confirm signal concordance .
Structural modeling: Predict epitope-paralog overlap using tools like AlphaFold to identify non-conserved regions .
How to design a robust study linking HMGB15 to transcriptional regulation?
Experimental pipeline:
Gene co-expression networks: Identify HMGB15-associated transcription factors (e.g., MYC2) via RNA-seq in mutants .
Functional rescue: Express epitope-tagged HMGB15 in athmgb15-4 mutants to restore JA-responsive gene expression .
Single-cell analysis: Use scRNA-seq to map HMGB15’s spatial expression in pollen developmental stages .
How to interpret unexpected HMGB15 antibody signals (e.g., multiple bands)?
Troubleshooting guide:
What statistical approaches validate HMGB15’s role in large-scale omics datasets?
Recommendations:
Functional role: HMGB15 directly binds promoters of JA-signaling genes (MYC2, MYB21, MYB24) in Arabidopsis, regulating pollen development .
Antibody specificity: Only 1/5 commercial HMGB1 antibodies showed no cross-reactivity with HMGB2 in murine models, underscoring rigorous validation needs .
Therapeutic parallels: Monoclonal anti-HMGB1 antibodies (e.g., 2G7) reduced inflammation in arthritis models, suggesting HMGB-family proteins as conserved therapeutic targets .